Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by greenupon Nov 13, 2018 9:21pm
106 Views
Post# 28969516

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Just checking in

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Just checking inDumb and dumber The only company that soft bashes and magnifies its issues.
MomentumMan wrote: You have to wonder wtf Jakob was thinking in that interview. All negativity is no good.Think before you speak Jakob. 

Vic was talking a few weeks back about getting daily calls from US institutions that want in. Where are they if that was the case? Maybe time to return some of those calls?

Near unbelieveable when I compare valuations. Disgusted.
 

greenup wrote: no offense but apH has been absolute garbge so far this year, i made good money with ACB, EMH and HEXO and reinvested in APH and got in all the way to from 9 to 19s assuming good things are happening. What I got in return was supply issue talks and labor shortage issue instead of a bit pumping.

I understand you are cozy and entered at $2 but for most of us trying to make a few$ and using some margins, it is going badly. 

nobody to blame but myself, however, I was not expecting to be bashed by our CEO by talking about supply issues instead of bringing positive information forward like lowest cost per gram etc. 

no seat in Vegas to attract new investors, no interviews at US media nothing, no wonder we are nearing cron despite their mediocre numbers 



 



INVSTIGAT0R wrote: Exactly. APH is the best value, period. Greenup, think of it this way: Everyone and their mom knew 3.2 billion for Medreleaf was horrendous, same with 1.1 billion for CMED. Do you really think a giant is going to come along and pay a premium on a company that has only got as big as they are by already paying huge premiums? Technically if Diageo somehow took an equity stake in Aurora they would be paying a premium on top of the HUGE premiums already offered for Medreleaf and CMED. Makes zero sense. That would literally be a pyramid scheme. Industry giants are not that stupid. Aurora is though so they'll just sign a JV and that's it. MAYBE an equity stake at a very small premium best case scenario for Aurora. 






Bullboard Posts